PharmatrophiX Obtains $10,300,000 New Funding Round

  • Feed Type
  • Date
    11/23/2015
  • Company Name
    PharmatrophiX
  • Mailing Address
    2300 Wells Fargo Capitol Center Raleigh, NC 27601 USA
  • Company Description
    PharmatrophiX is a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
  • Website
    http://www.pharmatrophix.com
  • Transaction Type
    Debt
  • Transaction Amount
    $10,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy